| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 8,614,700 | 7,759,300 | 7,624,600 | 7,828,100 | | Cost of Revenue |
-
| 5,793,700 | 16,930,500 | (5,086,200) | | | Gross Profit | 8,614,700 | 1,965,600 | (9,305,900) | 12,914,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 7,859,800 | 1,517,900 | (9,814,500) | 12,138,300 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
| (11,300) | (16,500) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 754,900 | 447,700 | 519,900 | 792,500 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (24,500) | (108,200) | 43,800 |
-
| | Earnings Before Interest And Taxes | 730,400 | 339,500 | 563,700 | 792,500 | | Interest Expense | 61,500 | (15,600) | 141,000 | 56,600 | | Income Before Tax | 668,900 | 355,100 | 422,700 | 735,900 | | Income Tax Expense | 231,100 | 160,400 | 145,400 | 255,400 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 437,800 | 194,700 | 277,300 | 480,500 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 437,800 | 194,700 | 277,300 | 480,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $437,800 | $194,700 | $277,300 | $480,500 |
|
0.45% Nasdaq 
0.20%
Income Statement
